Holding(s) in Company

TR-1: Standard form for notification of major holdings
NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)
1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: AstraZeneca PLC
1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)
Non-UK issuer
2. Reason for the notification (please mark the appropriate box or boxes with an "X")
An acquisition or disposal of voting rights X
An acquisition or disposal of financial instruments X
An event changing the breakdown of voting rights
Other (please specify):
3. Details of person subject to the notification obligation
Name Wellington Management Company LLP
City and country of registered office (if applicable) Boston, USA
4. Full name of shareholder(s)  (if different from 3)
Name Bank of New York (Nominees) LtdBBH ISL NOMINEES LTDBNY (OCS) Nominees LimitedBNY Mellon Nominees LimitedGOLDMAN SACHS INTERNATIONALHSBC Global Custody Nominee (UK) LimitedJapan Trustee Services Bank Ltd.JP Morgan Chase Nominees LimitedMellon Nominees (UK) Ltd.Nortrust Nominees LimitedROY Nominees LimitedState Street Nominees LimitedVIDACOS NOMINEES LIMITED
City and country of registered office (if applicable)
5. Date on which the threshold was crossed or reached: 20/07/2020
6. Date on which issuer notified (DD/MM/YYYY): 21/07/2020
7. Total positions of person(s) subject to the notification obligation:
% of voting rights attached to shares(total of 8.A) % of voting rights through financial instruments(total of 8.B.1 + 8.B.2) Total of both in %(8.A + 8.B) Total number of voting rights of issuer
Resulting situation on the date on which threshold was crossed or reached 2.95% 2.01% 4.96% 1,312,271,081
Position of previous notification (if applicable) 2.97% 2.04% 5.01%
8. Notified details of the resulting situation on the date on which the threshold was crossed or reached:
A: Voting rights attached to shares
Class/type of shares ISIN code (if possible) Number of voting rights % of voting rights
Direct(Art 9 of Directive 2004/109/EC) (DTR5.1) Indirect(Art 10 of Directive 2004/109/EC) (DTR5.2.1) Direct(Art 9 of Directive 2004/109/EC) (DTR5.1) Indirect(Art 10 of Directive 2004/109/EC) (DTR5.2.1)
GB0009895292 Ordinary Shares 38,723,069 2.95%
SUBTOTAL 8.A 38,723,069 2.95%
B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))
Type of financial instrument Expiration date Exercise/ Conversion Period Number of voting rights that may be acquired if the instrument is exercised/converted % of voting rights
Depository Receipt 51,934,556 Depository Receipt shares or 25,967,241 votes on a converted basis 1.98%
SUBTOTAL 8.B.1 25,967,241 1.98%
B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))
Type of financial instrument Expiration date Exercise/ Conversion Period Physical or cash settlement Number of voting rights % of voting rights
Equity Swap 29/01/2021 03/02/2020to29/01/2021 Cash settlement 183,970 Equity Swap shares or 91,985 votes on a converted basis 0.01%
Equity Swap 31/12/2020 05/12/2019to31/12/2020 Cash settlement 140,896 Equity Swap shares or 70,448 votes on a converted basis 0.01%
Equity Swap 30/04/2021 04/05/2020to30/04/2021 Cash settlement 57,837 Equity Swap shares or 28,918 votes on a converted basis 0.00%
Equity Swap 30/06/2021 02/07/2020to30/06/2021 Cash settlement 56,143 Equity Swap shares or 28,071 votes on a converted basis 0.00%
Equity Swap 31/03/2021 02/04/2020to31/03/2021 Cash settlement 55,558 Equity Swap shares or 27,779 votes on a converted basis 0.00%
Equity Swap 31/08/2020 08/08/2019to31/08/2020 Cash settlement 42,723 Equity Swap shares or 21,361 votes on a converted basis 0.00%
Equity Swap 15/05/2023 09/08/2018to15/05/2023 Cash settlement 19,846 Equity Swap shares or 19,846 votes on a converted basis 0.00%
Equity Swap 15/05/2023 20/02/2019to15/05/2023 Cash settlement 35,896 Equity Swap shares or 17,948 votes on a converted basis 0.00%
Equity Swap 15/05/2023 02/03/2018to15/05/2023 Cash settlement 11,419 Equity Swap shares or 11,419 votes on a converted basis 0.00%
Equity Swap 15/05/2023 10/10/2017to15/05/2023 Cash settlement 8,928 Equity Swap shares or 8,928 votes on a converted basis 0.00%
Equity Swap 22/05/2023 08/10/2018to22/05/2023 Cash settlement 7,796 Equity Swap shares or 7,796 votes on a converted basis 0.00%
Index Future 20/07/2020 01/01/1900to20/07/2020 Cash settlement 1,394 Index Future shares or 7,186 votes on a converted basis 0.00%
Equity Swap 22/05/2023 05/10/2018to22/05/2023 Cash settlement 6,487 Equity Swap shares or 6,487 votes on a converted basis 0.00%
Equity Swap 15/05/2023 09/02/2018to15/05/2023 Cash settlement 6,300 Equity Swap shares or 6,300 votes on a converted basis 0.00%
Equity Swap 22/05/2023 15/07/2019to22/05/2023 Cash settlement 6,212 Equity Swap shares or 6,212 votes on a converted basis 0.00%
Equity Swap 22/05/2023 15/06/2020to22/05/2023 Cash settlement 5,919 Equity Swap shares or 5,919 votes on a converted basis 0.00%
Equity Swap 22/05/2023 23/08/2019to22/05/2023 Cash settlement 4,413 Equity Swap shares or 4,413 votes on a converted basis 0.00%
Equity Swap 05/05/2023 03/06/2020to05/05/2023 Cash settlement 3,967 Equity Swap shares or 3,967 votes on a converted basis 0.00%
Equity Swap 15/05/2023 02/02/2018to15/05/2023 Cash settlement 3,782 Equity Swap shares or 3,782 votes on a converted basis 0.00%
Equity Swap 22/05/2023 03/07/2018to22/05/2023 Cash settlement 3,496 Equity Swap shares or 3,496 votes on a converted basis 0.00%
Equity Swap 22/05/2023 06/01/2020to22/05/2023 Cash settlement 3,382 Equity Swap shares or 3,382 votes on a converted basis 0.00%
Equity Swap 22/05/2023 08/01/2019to22/05/2023 Cash settlement 3,207 Equity Swap shares or 3,207 votes on a converted basis 0.00%
Equity Swap 22/05/2023 05/04/2018to22/05/2023 Cash settlement 2,982 Equity Swap shares or 2,982 votes on a converted basis 0.00%
Equity Swap 15/05/2023 02/07/2018to15/05/2023 Cash settlement 2,827 Equity Swap shares or 2,827 votes on a converted basis 0.00%
Equity Swap 15/05/2023 23/10/2017to15/05/2023 Cash settlement 2,779 Equity Swap shares or 2,779 votes on a converted basis 0.00%
Equity Swap 05/05/2023 20/08/2019to05/05/2023 Cash settlement 5,393 Equity Swap shares or 2,696 votes on a converted basis 0.00%
Equity Swap 22/05/2023 02/06/2020to22/05/2023 Cash settlement 4,154 Equity Swap shares or 2,077 votes on a converted basis 0.00%
Equity Swap 15/05/2023 28/05/2020to15/05/2023 Cash settlement 3,963 Equity Swap shares or 1,981 votes on a converted basis 0.00%
Equity Swap 22/05/2023 10/07/2020to22/05/2023 Cash settlement 1,830 Equity Swap shares or 1,830 votes on a converted basis 0.00%
Equity Swap 15/05/2023 16/07/2018to15/05/2023 Cash settlement 1,776 Equity Swap shares or 1,776 votes on a converted basis 0.00%
Equity Swap 22/05/2023 14/04/2020to22/05/2023 Cash settlement 3,326 Equity Swap shares or 1,663 votes on a converted basis 0.00%
Equity Swap 22/05/2023 05/06/2020to22/05/2023 Cash settlement 1,570 Equity Swap shares or 1,570 votes on a converted basis 0.00%
Equity Swap 15/05/2023 26/06/2020to15/05/2023 Cash settlement 2,796 Equity Swap shares or 1,398 votes on a converted basis 0.00%
Equity Swap 15/05/2023 11/06/2018to15/05/2023 Cash settlement 1,367 Equity Swap shares or 1,367 votes on a converted basis 0.00%
Equity Swap 05/05/2023 31/07/2019to05/05/2023 Cash settlement 2,654 Equity Swap shares or 1,327 votes on a converted basis 0.00%
Equity Swap 05/05/2023 12/08/2019to05/05/2023 Cash settlement 1,926 Equity Swap shares or 963 votes on a converted basis 0.00%
Equity Swap 22/05/2023 08/06/2020to22/05/2023 Cash settlement 1,841 Equity Swap shares or 920 votes on a converted basis 0.00%
Equity Swap 15/05/2023 08/10/2019to15/05/2023 Cash settlement 1,721 Equity Swap shares or 860 votes on a converted basis 0.00%
Equity Swap 22/05/2023 20/01/2020to22/05/2023 Cash settlement 829 Equity Swap shares or 829 votes on a converted basis 0.00%
Equity Swap 15/05/2023 14/06/2019to15/05/2023 Cash settlement 1,593 Equity Swap shares or 796 votes on a converted basis 0.00%
Equity Swap 22/05/2023 06/07/2020to22/05/2023 Cash settlement 1,587 Equity Swap shares or 793 votes on a converted basis 0.00%
Equity Swap 05/05/2023 14/07/2020to05/05/2023 Cash settlement 1,504 Equity Swap shares or 752 votes on a converted basis 0.00%
Equity Swap 22/05/2023 01/11/2019to22/05/2023 Cash settlement 1,308 Equity Swap shares or 654 votes on a converted basis 0.00%
Equity Swap 22/05/2023 13/05/2020to22/05/2023 Cash settlement 1,308 Equity Swap shares or 654 votes on a converted basis 0.00%
Equity Swap 15/05/2023 16/05/2019to15/05/2023 Cash settlement 1,290 Equity Swap shares or 645 votes on a converted basis 0.00%
Equity Swap 15/05/2023 27/07/2018to15/05/2023 Cash settlement 600 Equity Swap shares or 600 votes on a converted basis 0.00%
Equity Swap 15/05/2023 29/06/2020to15/05/2023 Cash settlement 1,128 Equity Swap shares or 564 votes on a converted basis 0.00%
Equity Swap 15/05/2023 31/03/2020to15/05/2023 Cash settlement 1,052 Equity Swap shares or 526 votes on a converted basis 0.00%
Equity Swap 05/05/2023 03/02/2020to05/05/2023 Cash settlement 1,037 Equity Swap shares or 518 votes on a converted basis 0.00%
Equity Swap 22/05/2023 06/01/2020to22/05/2023 Cash settlement 516 Equity Swap shares or 516 votes on a converted basis 0.00%
Equity Swap 22/05/2023 08/10/2018to22/05/2023 Cash settlement 486 Equity Swap shares or 486 votes on a converted basis 0.00%
Equity Swap 05/05/2023 15/08/2019to05/05/2023 Cash settlement 841 Equity Swap shares or 420 votes on a converted basis 0.00%
Equity Swap 05/05/2023 13/08/2019to05/05/2023 Cash settlement 834 Equity Swap shares or 417 votes on a converted basis 0.00%
Equity Swap 05/05/2023 02/08/2019to05/05/2023 Cash settlement 818 Equity Swap shares or 409 votes on a converted basis 0.00%
Equity Swap 15/05/2023 26/07/2019to15/05/2023 Cash settlement 647 Equity Swap shares or 323 votes on a converted basis 0.00%
Equity Swap 22/05/2023 03/10/2019to22/05/2023 Cash settlement 162 Equity Swap shares or 162 votes on a converted basis 0.00%
Equity Swap 22/05/2023 21/04/2020to22/05/2023 Cash settlement 131 Equity Swap shares or 131 votes on a converted basis 0.00%
Equity Swap 05/05/2023 13/09/2019to05/05/2023 Cash settlement 40 Equity Swap shares or 40 votes on a converted basis 0.00%
SUBTOTAL 8.B.2 428,101 0.03%
9. Information in relation to the person subject to the notification obligation (please mark the applicable box with an "X")
Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.
Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) X
Name % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher than the notifiable threshold Total of both if it equals or is higher than the notifiable threshold
Wellington Management Company LLP
10. In case of proxy voting, please identify:
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional information:
Place of completion London
Date of completion 21/07/2020

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

About Us

AstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009. For more information please visit: www.astrazeneca.com

Subscribe

Documents & Links